Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocannabinoid signaling in the brain.

Rachel I Wilson1, Roger A Nicoll

  • 1Division of Biology, 139-74, California Institute of Technology, Pasadena, CA 91125, USA.

Science (New York, N.Y.)
|April 27, 2002
PubMed
Summary

Delta9-tetrahydrocannabinol (Delta9-THC), a cannabis compound, activates brain CB1 receptors. This mechanism influences neurotransmitter release, potentially affecting memory, cognition, and pain perception.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reassessment of NMDA receptor-dependent presynaptic homeostatic plasticity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Distributed control circuits across a brain-and-cord connectome.

Nature·2026
Same author

Specialized parallel pathways for adaptive control of visual object pursuit.

Neuron·2026
Same author

Localization and Functional Characterization of MDGA1 in Mouse Hippocampus.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

LTP: A Personal Journey and Beyond.

Hippocampus·2026
Same author

Modulating synaptic glutamate receptors by targeting network nodes of the postsynaptic density condensate.

Molecular cell·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cannabinoid Research

Background:

  • The primary psychoactive component of cannabis, Delta9-tetrahydrocannabinol (Delta9-THC), interacts with the central nervous system.
  • Cannabinoid receptor 1 (CB1) is a key target, highly expressed in numerous brain regions.
  • Endogenous cannabinoids act as retrograde messengers, modulating synaptic transmission.

Purpose of the Study:

  • To elucidate the mechanism by which Delta9-THC and endogenous cannabinoids influence neuronal signaling.
  • To explore the role of CB1 receptor activation in synaptic plasticity and neurotransmitter release.
  • To understand the cellular basis for cannabinoid effects on cognitive and sensory functions.

Main Methods:

  • Investigated the interaction of Delta9-THC with CB1 receptors.
  • Examined the function of endogenous cannabinoids as retrograde synaptic messengers.
  • Analyzed the impact of cannabinoid signaling on neurotransmitter release from presynaptic neurons.

Main Results:

  • Delta9-THC primarily acts by activating CB1 receptors in the brain.
  • Endogenous cannabinoids function uniquely as retrograde messengers, released from postsynaptic neurons.
  • Activation of presynaptic CB1 receptors by retrograde cannabinoids suppresses neurotransmitter release.

Conclusions:

  • Cannabinoids, including Delta9-THC, modulate synaptic transmission through CB1 receptor activation.
  • The retrograde signaling of endogenous cannabinoids provides a cellular mechanism for their effects.
  • This mechanism is implicated in the influence of cannabinoids on memory, cognition, and pain perception.

Related Experiment Videos